Our Latest
Moxe Health Raises $30M Series B to Further Advance Interoperability
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics
Apella Announces $21 Million Series A Funding to Digitize the Operating Room
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
September 27, 2021 MINNEAPOLIS & WASHINGTON, DC—(BUSINESS WIRE)—Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s investors in its inaugural fund alongside select new institutional investors. Vensana Capital launched in 2019 […]
Vensana’s Kirk Nielsen to Co-Chair the 2021 Medtech Venture & Partnering Conference in Minneapolis
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
This AI Startup Raised $43 Million To Save Lives (And Money) By Treating Heart Disease Earlier
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease
GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate™ Cell Processing System for Next-Generation Cell & Gene Therapies
Vensana Capital Founders Offer Public Comments in Support of CMS Final Rule, “Medicare Program; Medicare Coverage of Innovative Technology (MCIT)”
Vensana Capital, a medical technology-focused venture capital firm based in Minneapolis and Washington, DC, is submitting this letter in response to the interim final rule delaying the effective date and requesting additional comment on the final rule establishing the MCIT coverage pathway for Food and Drug Administration (FDA)- designated breakthrough medical devices (“Notice of Delay”).1 […]
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
CVRx® Raises $50 Million in New Equity Financing
Klein to speak at Life Sciences Future – MedTech
Eight VCs Join NVCA Board and Barry Eggers of Lightspeed Appointed Chair
GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Vensana—Is Medtech Investing on the Rebound?
Medtech investor duo seeks to ‘fill the gap’ in device sector private funding
New Minnesota-based fund has $225 million to invest in young med-tech companies
New med-tech investment firm Vensana Capital launches $225 million fund
Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund
Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty
New Medtech Investor Vensana Closes $225 Million Debut Fund
Vensana Capital Launches with Inaugural $225 Million Fund
Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana
Kirk Nielsen featured at MedTech Strategist Medical Alley Innovation Summit 2019
Vensana Capital Co-Organizes 26th Annual Phoenix Conference
TEDCO to Host Entrepreneur Expo on October 29 – Vensana Capital’s Justin Klein and AllegisCyber’s Bob Ackerman morning keynotes at the Expo
TEDCO’s annual Entrepreneur Expo was established to spotlight entrepreneurship in the region by bringing together Maryland’s various resources for a day of celebration.